BACKGROUND: In 1994, an International Task Force proposed criteria for the clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated recognition and interpretation of the frequently nonspecific clinical features of ARVC/D. This enabled confirmatory clinical diagnosis in index cases through exclusion of phenocopies and provided a standard on which clinical research and genetic studies could be based. Structural, histological, electrocardiographic, arrhythmic, and familial features of the disease were incorporated into the criteria, subdivided into major and minor categories according to the specificity of their association with ARVC/D. At that time, clinical experience with ARVC/D was dominated by symptomatic index cases and sudden cardiac death victims-the overt or severe end of the disease spectrum. Consequently, the 1994 criteria were highly specific but lacked sensitivity for early and familial disease. METHODS AND RESULTS: Revision of the diagnostic criteria provides guidance on the role of emerging diagnostic modalities and advances in the genetics of ARVC/D. The criteria have been modified to incorporate new knowledge and technology to improve diagnostic sensitivity, but with the important requisite of maintaining diagnostic specificity. The approach of classifying structural, histological, electrocardiographic, arrhythmic, and genetic features of the disease as major and minor criteria has been maintained. In this modification of the Task Force criteria, quantitative criteria are proposed and abnormalities are defined on the basis of comparison with normal subject data. CONCLUSIONS: The present modifications of the Task Force Criteria represent a working framework to improve the diagnosis and management of this condition. Clinical Trial Registration clinicaltrials.gov Identifier: NCT00024505.
BACKGROUND: In 1994, an International Task Force proposed criteria for the clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated recognition and interpretation of the frequently nonspecific clinical features of ARVC/D. This enabled confirmatory clinical diagnosis in index cases through exclusion of phenocopies and provided a standard on which clinical research and genetic studies could be based. Structural, histological, electrocardiographic, arrhythmic, and familial features of the disease were incorporated into the criteria, subdivided into major and minor categories according to the specificity of their association with ARVC/D. At that time, clinical experience with ARVC/D was dominated by symptomatic index cases and sudden cardiac death victims-the overt or severe end of the disease spectrum. Consequently, the 1994 criteria were highly specific but lacked sensitivity for early and familial disease. METHODS AND RESULTS: Revision of the diagnostic criteria provides guidance on the role of emerging diagnostic modalities and advances in the genetics of ARVC/D. The criteria have been modified to incorporate new knowledge and technology to improve diagnostic sensitivity, but with the important requisite of maintaining diagnostic specificity. The approach of classifying structural, histological, electrocardiographic, arrhythmic, and genetic features of the disease as major and minor criteria has been maintained. In this modification of the Task Force criteria, quantitative criteria are proposed and abnormalities are defined on the basis of comparison with normal subject data. CONCLUSIONS: The present modifications of the Task Force Criteria represent a working framework to improve the diagnosis and management of this condition. Clinical Trial Registration clinicaltrials.gov Identifier: NCT00024505.
Authors: Ernst Wellnhofer; Peter Ewert; Jürgen Hug; Wei Hui; Oliver Kretschmar; Disthapron Chavengsuk; Titus Kühne; Hashim Abdul-Khaliq; Eike Nagel; Peter E Lange; Eckart Fleck Journal: Int J Cardiovasc Imaging Date: 2005-12 Impact factor: 2.357
Authors: Julia H Indik; William J Dallas; Theron Ovitt; Thomas Wichter; Kathleen Gear; Frank I Marcus Journal: Cardiology Date: 2005-05-28 Impact factor: 1.869
Authors: Mark Norman; Michael Simpson; Jens Mogensen; Anthony Shaw; Sîan Hughes; Petros Syrris; Srijita Sen-Chowdhry; Edward Rowland; Andrew Crosby; William J McKenna Journal: Circulation Date: 2005-08-02 Impact factor: 29.690
Authors: Moniek G P J Cox; Jasper J van der Smagt; Arthur A M Wilde; Ans C P Wiesfeld; Douwe E Atsma; Marcel R Nelen; Luz-Maria Rodriguez; Peter Loh; Maarten J Cramer; Pieter A Doevendans; J Peter van Tintelen; Jacques M T de Bakker; Richard N W Hauer Journal: Circ Arrhythm Electrophysiol Date: 2009-07-07
Authors: Kalpana R Prakasa; Darshan Dalal; Jianwen Wang; Chandra Bomma; Harikrishna Tandri; Jun Dong; Cynthia James; Crystal Tichnell; Stuart D Russell; Philip Spevak; Mary Corretti; David A Bluemke; Hugh Calkins; Theodore P Abraham Journal: Am J Cardiol Date: 2006-01-13 Impact factor: 2.778
Authors: Giorgia Beffagna; Gianluca Occhi; Andrea Nava; Libero Vitiello; Andrea Ditadi; Cristina Basso; Barbara Bauce; Gianni Carraro; Gaetano Thiene; Jeffrey A Towbin; Gian Antonio Danieli; Alessandra Rampazzo Journal: Cardiovasc Res Date: 2005-02-01 Impact factor: 10.787
Authors: Francesca Cittadini; Nadia De Giovanni; Mireia Alcalde; Sara Partemi; Arnaldo Carbone; Oscar Campuzano; Ramon Brugada; Antonio Oliva Journal: Int J Legal Med Date: 2014-11-16 Impact factor: 2.686
Authors: Adil Rajwani; Michael J Stewart; James D Richardson; Nicholas M Child; Neil Maredia Journal: Br J Radiol Date: 2015-10-23 Impact factor: 3.039
Authors: C L Hertz; S L Christiansen; L Ferrero-Miliani; M Dahl; P E Weeke; G L Ottesen; R Frank-Hansen; H Bundgaard; N Morling Journal: Int J Legal Med Date: 2015-09-17 Impact factor: 2.686
Authors: Ammar M Killu; Alan M Sugrue; Siva K Mulpuru; Christopher J McLeod; David O Hodge; Peter A Noseworthy; Lisa Fanning; Thomas M Munger; Douglas L Packer; Samuel J Asirvatham; Paul A Friedman Journal: J Interv Card Electrophysiol Date: 2016-05-18 Impact factor: 1.900